Windlas Biotech Share Price
(WINDLAS)
Check the latest share price of Windlas Biotech, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 12 May 2025
NSE
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -6.39 % |
3 Month Return | + 19.9 % |
1 Year Return | + 94.88 % |
3 Year Return | + 340.33 % |
5 Year Return | + 145.93 % |
Market Stats | |
Previous Close | ₹982.55 |
Open | ₹1,034.95 |
Volume | 39.20K |
Upper Circuit | ₹1,179.05 |
Lower Circuit | ₹786.05 |
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹2,092.75 Cr
Return on Equity (ROE)
13.63
PE Ratio (TTM)
33.85
Return on capital employed (ROCE)
18.03
Industry PE ratio
53.64
Beta (LTM)
1.22
P/B Ratio
2.37
Dividend Yield
1.07
PEG Ratio
7.68
Quarterly Earnings Growth YOY
3.18
EPS (TTM)
27.98
Sector
Pharmaceuticals
Book Value
216.34
Technical Analysis
Bullish
View Technical Analysis
Investing in Windlas Biotech is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Windlas Biotech or WINDLAS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Windlas Biotech or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Windlas Biotech with just a few clicks!
Track how the P/E of Windlas Biotech has moved over time to understand valuation trends.
Windlas Biotech in the last 5 years
Lowest (10.46x)
March 28, 2023
Today (33.85x)
May 12, 2025
Industry (53.64x)
May 12, 2025
Highest (38.93x)
December 6, 2024
Today’s Price to Earnings Ratio: 33.85x
Get the annual and quarterly financial summary of Windlas Biotech, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Windlas Biotech.
Windlas Biotech Ltd’s net profit jumped 3.18% since last year same period to ₹15.58Cr in the Q3 2024-2025. On a quarterly growth basis, Windlas Biotech Ltd has generated -0.51% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Windlas Biotech Ltd has declared dividend of ₹5.50 - translating a dividend yield of 0.55%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Windlas Biotech.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 62.34% | 0.00 | |
Foreign Institutions | 1.52% | 0.00 | |
Mutual Funds | 6.7% | 0.00 | |
Retail Investors | 25.25% | 0.00 | |
Others | 4.19% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Windlas Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 2,092.75 | 29.19% | 0.51 | 58 | 630 | |
NA | 122.69 | 100.86% | 0.50 | 14 | 95 | |
NA | 70.03 | 94.93% | 2.00 | 14 | 502 | |
NA | 105.17 | 71.57% | 0.50 | 9 | 188 | |
NA | 50.03 | 42.59% | 0.50 | 1 | 67 |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 9 quarters, 121.87 Cr → 199.13 Cr (in ₹), with an average increase of 5.9% per quarter
Best in 1 Year
In the last 1 year, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 3 months, WINDLAS stock has moved up by 14.6%
Best in 3 Years
In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
MF Holding Down
Mutual Funds have decreased holdings from 7.11% to 6.70% in Mar 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 1.55% to 1.52% in Mar 2025 quarter
Profit Down
Netprofit is down for the last 2 quarters, 15.66 Cr → 15.58 Cr (in ₹), with an average decrease of 0.5% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 25.68% to 25.25% in Mar 2025 quarter
Promoter Holding Down
Promoters have decreased holdings from 62.51% to 62.34% in Mar 2025 quarter
Organisation | Windlas Biotech Ltd |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
CEO | Vivek Dhariwal |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Windlas Biotech.
Windlas Biotech Ltd share price today stands at ₹1001.3, Open: ₹1034.95, Previous Close: ₹982.55, High: ₹1034.95, Low: ₹985.35, 52 Week High: ₹1198.25, 52 Week Low: ₹495.65.
Today's traded volume of Windlas Biotech Ltd(WINDLAS) is 39.20K.
Today's market capitalisation of Windlas Biotech Ltd(WINDLAS) is ₹2,092.75 Cr.
Windlas Biotech Ltd (WINDLAS) share price is ₹1001.3. It is down -16.44% from its 52 Week High price of ₹1198.25
Windlas Biotech Ltd (WINDLAS) share price is ₹1001.3. It is up 102.02% from its 52 Week Low price of ₹495.65